Balboa Wealth Partners Novo Nordisk A S Transaction History
Balboa Wealth Partners
- $389 Million
- Q3 2024
A detailed history of Balboa Wealth Partners transactions in Novo Nordisk A S stock. As of the latest transaction made, Balboa Wealth Partners holds 1,981 shares of NVO stock, worth $155,884. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,981
Previous 2,408
17.73%
Holding current value
$155,884
Previous $343,000
31.49%
% of portfolio
0.06%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding NVO
# of Institutions
1,928Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.59 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.13 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.13 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.05 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$961 Million3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $178B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...